These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31993450)
21. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT). Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282 [TBL] [Abstract][Full Text] [Related]
22. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564 [TBL] [Abstract][Full Text] [Related]
23. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. Na-Bangchang K; Karbwang J Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319 [TBL] [Abstract][Full Text] [Related]
24. High-throughput virtual screening approach involving pharmacophore mapping, ADME filtering, molecular docking and MM-GBSA to identify new dual target inhibitors of Rawat R; Verma SM J Biomol Struct Dyn; 2021 Sep; 39(14):5148-5159. PubMed ID: 32579074 [TBL] [Abstract][Full Text] [Related]
25. Novel series of 1,2,4-trioxane derivatives as antimalarial agents. Rudrapal M; Chetia D; Singh V J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents. Bekhit AA; Saudi MN; Hassan AMM; Fahmy SM; Ibrahim TM; Ghareeb D; El-Seidy AM; Nasralla SN; Bekhit AEA Eur J Med Chem; 2019 Feb; 163():353-366. PubMed ID: 30530172 [TBL] [Abstract][Full Text] [Related]
28. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes. Summers KL Mini Rev Med Chem; 2019; 19(7):569-590. PubMed ID: 30324878 [TBL] [Abstract][Full Text] [Related]
29. Virtual Screening Techniques to Probe the Antimalarial Activity of some Traditionally Used Phytochemicals. Shibi IG; Aswathy L; Jisha RS; Masand VH; Gajbhiye JM Comb Chem High Throughput Screen; 2016; 19(7):572-91. PubMed ID: 27095535 [TBL] [Abstract][Full Text] [Related]
31. Drug resistance in malaria. Parija SC; Praharaj I Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103 [TBL] [Abstract][Full Text] [Related]
32. Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio. Chaparro MJ; Calderón F; Castañeda P; Fernández-Alvaro E; Gabarró R; Gamo FJ; Gómez-Lorenzo MG; Martín J; Fernández E ACS Infect Dis; 2018 Apr; 4(4):568-576. PubMed ID: 29320160 [TBL] [Abstract][Full Text] [Related]
33. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346 [TBL] [Abstract][Full Text] [Related]
34. From hybrid compounds to targeted drug delivery in antimalarial therapy. Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864 [TBL] [Abstract][Full Text] [Related]
35. Resistance to antimalarial compounds: methods and applications. Witkowski B; Berry A; Benoit-Vical F Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915 [TBL] [Abstract][Full Text] [Related]
36. The current status of antimalarial drug research with special reference to application of QSAR models. Ojha PK; Roy K Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681 [TBL] [Abstract][Full Text] [Related]
37. Antimalarial Phytochemicals Identification from Shah AP; Parmar GR; Sailor GU; Seth AK Folia Med (Plovdiv); 2019 Dec; 61(4):584-593. PubMed ID: 32337872 [TBL] [Abstract][Full Text] [Related]
38. Fragment-based virtual screening identifies novel leads against Plasmepsin IX (PlmIX) of Almuqdadi HTA; Kifayat S; Anwer R; Alrehaili J; Abid M Front Pharmacol; 2024; 15():1387629. PubMed ID: 38846093 [TBL] [Abstract][Full Text] [Related]
39. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum. Kumari M; Chandra S; Tiwari N; Subbarao N BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744 [TBL] [Abstract][Full Text] [Related]
40. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives. Vijayaraghavan S; Mahajan S Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]